%D8%A5%D9%8A%D9%81%D9%8A%D8%B1%D9%88%D9%84%D9%8A%D9%85%D9%88%D8%B3%D8%A7%D9%88%D8%B1%D9%88%D9%84%DB%8C%D9%85%D8%B3Category:EverolimusEverolimusEverolimusEverolimus%D8%A7%D9%88%D8%B1%D9%88%D9%84%DB%8C%D9%85%D8%B3%C3%89v%C3%A9rolimusEverolimus%E3%82%A8%E3%83%99%E3%83%AD%E3%83%AA%E3%83%A0%E3%82%B9EverolimusEverolimusEwerolimusEverolimo%D0%AD%D0%B2%D0%B5%D1%80%D0%BE%D0%BB%D0%B8%D0%BC%D1%83%D1%81EverolimusEverolimus%D0%95%D0%B2%D0%B5%D1%80%D0%BE%D0%BB%D1%96%D0%BC%D1%83%D1%81EverolimusQ421052
about
sameAs
P1855
renal cell carcinomacholangiocarcinomainsulinomacarcinoid tumorneuroendocrine carcinomarenal clear cell carcinomasmall intestine carcinomakidney angiomyolipomaneuroendocrine tumorlymphomadiffuse large B-cell lymphomaacute myeloid leukemiakidney cancercarcinomacarcinoid syndromeangiomyolipomalow-grade astrocytomabenign neoplasm of braintuberous sclerosis 1Islet cell carcinoma
P2176
P3355
The Impact of Everolimus Based Immunosuppression in the Evolution of Hepatitis C Fibrosis After Liver TransplantationComparison of the Efficacy and Safety of Sirolimus Versus Everolimus Versus Mycophenolate in Kidney TransplantationMolecular Profiling-Based Targeted Therapy in Treating Patients With Advanced Solid TumorsCombination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk RhabdomyosarcomaXIENCE Xpedition Everolimus-Eluting Coronary Stent Japan Post Marketing Surveillance (XIENCE Xpedition SV Japan PMS)The Study of Active Transfer of Plaque Technique for Unprotected Distal Left Main Bifurcation LesionsAuranofin and Sirolimus in Treating Patients With Advanced Solid Tumors or Recurrent Non-Small Cell Lung CancerTrial of eRapa in Prostate Cancer PatientsA First-in-Man Study to Evaluate the Feasibility and Safety of Sirolimus-eluting Iron Bioresorbable Coronary Scaffold SystemCD40-L Blockade for Prevention of Acute Graft-Versus-Host DiseaseBIOFLOW-SV All Comers RegistryBIOFLOW-SV Portugal RegistryImmunomodulatory Effects of Rapamycin on Pregnancy Rate of Patient With Recurrent Implantation FailureNCT Neuro Master Match - N²M² (NOA-20)Evaluation of the Safety and Tolerability of Niraparib With Everolimus in Ovarian and BreastErlotinib and RAD001 (Everolimus) in Patients With Previously Treated Advanced Pancreatic CancerEverolimus (RAD001) in Elderly Patients With Acute Myeloid LeukemiaMolecular, Genetic, and Genomic Assessments From Patients Treated With RAD001ABI-009 Trial in Patients With Advanced Non-hematologic MalignanciesEvaluation of Early Conversion to Everolimus From Cyclosporine in de Novo Renal Transplant RecipientsA Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform NeurofibromasComparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaDiabetes Drug Eluting Sirolimus Stent Experience in Restenosis TrialXIENCE V: SPIRIT WOMENA Study of Diabetic Patients With De Novo Native Coronary Artery LesionsStudy Evaluating The Safety, Efficacy & Pharmacokinetics Of Temsirolimus(CCI-779) In Subjects With Advanced Renal Cell CarcinomaFibrosis in Renal AllograftsSirolimus Treatment in Patients With Autosomal Dominant Polycystic Kidney Disease: Renal Efficacy and SafetyTrial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAMNon-Myeloablative Bone Marrow Transplant for Patients With Sickle Cell Anemia and Other Blood DisordersFeasibility Study With the Sirolimus-Eluting BX Velocity Balloon-Expandable Stent in the Treatment of Diabetic Patients With Native Coronary Artery LesionsDiffuse Type In-Stent Restenosis After Drug-Eluting StentFocal In-stent Restenosis After Drug-Eluting StentCombination of RAD001 and Erlotinib in Patients With Advanced Non Small Cell Lung Cancer Previously Treated Only With ChemotherapyA Phase II Study of Belatacept (BMS-224818) With a Steroid-free Regimen in Subjects Undergoing Kidney TransplantationComparison of Stent Graft, Sirolimus Stent, and Bare Metal Stent Implanted in Patients With Acute Coronary SyndromeStudy Evaluating of Calcineurin Inhibitors Versus Sirolimus in Renal Allograft RecipientSirolimus in Treating Patients With HIV-Related Kaposi's SarcomaEverolimus (RAD001) as Therapy for Patients With Systemic MastocytosisTemsirolimus in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
P4844
AfinitorEverolimus / Letrozole combination therapyEverolimus / Bevacizumab combination therapyEverolimus / Erlotinib combination therapyEverolimus / Pazopanib combination therapyEverolimus / Octreotide combination therapyvandetanib / everolimus combination therapyFulvestrant / everolimus combination therapyeverolimus / binimetinib combination therapy
P527
description
Arzneistoff
@de
agent antinéoplasique et médicament immunosuppresseur
@fr
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de-ch
name
Everolimus
@de
Everolimus
@es
Everolimus
@it
Everolimus
@nb
Everolimus
@nl
Everolimus
@sh
Everolimus
@vi
everolimo
@pt
everolimus
@en
everolimus
@nn
type
label
Everolimus
@de
Everolimus
@es
Everolimus
@it
Everolimus
@nb
Everolimus
@nl
Everolimus
@sh
Everolimus
@vi
everolimo
@pt
everolimus
@en
everolimus
@nn
altLabel
40-O-(2-hydroxyethyl)-rapamycin
@en
42-O-(2-hydroxyethyl)rapamycin
@en
Afinitor
@nb
Afinitor
@pt
RAD-001
@de
RAD-001
@pl
RAD001
@en
SDZ-RAD
@en
everolimus
@it
アフィニトール
@ja
prefLabel
Everolimus
@de
Everolimus
@es
Everolimus
@it
Everolimus
@nb
Everolimus
@nl
Everolimus
@sh
Everolimus
@vi
everolimo
@pt
everolimus
@en
everolimus
@nn